Quebec Consortium for Drug Discovery, Brain Canada Offer C$10M for Multidisciplinary Collaborations | GenomeWeb

NEW YORK (GenomeWeb) – The Quebec Consortium for Drug Discovery (CQDM) and the nonprofit Brain Canada plan to provide at least C$10 million (US$9.2 million) for researchers developing tools, technologies, and platforms that will speed drug development for brain and nervous system disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.